SCHEMBL6277355

SCHEMBL6277355

O=C(OCc1cccc2cc3ccccc3cc12)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.53
BCL9 O00512 1/20 0.44
CTNNB1 P35222 1/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MGLL Q99685 1/20 0.43
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
MCL1 Q07820 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
CYP19A1 P11511 2/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PTPN7 P35236 1/20 0.41
PTPN12 Q05209 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6394617 0.90 HTR2A (0.52) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL2397708 0.85 HTR2A (0.52) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL2395338 0.82 HTR2A (0.49) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL30221714 0.82 HTR2A (0.51) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL6395093 0.81 HTR2A (0.62) HTR2AALDH1A1GAAKDM4EMGLL
SCHEMBL13736848 0.81 HTR2A (0.55) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL23056443 0.80 HTR2A (0.54) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL8410730 0.80 HTR2A (0.54) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL29629121 0.80 HTR2A (0.54) HTR2ABCL9CTNNB1ALDH1A1GAA
SCHEMBL9140032 0.80 HTR2A (0.57) HTR2ABCL9CTNNB1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077962-B1 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE US GOV HEALTH & HUMAN SERV (US) 2005-04-13 EP claimed
US-6656737-B1 Reacting 9-anthracenemethanol, pyridine, and p-nitrophenyl chloroformate; reacting the product with an amine, especially piperazine, to form a product that can be used to determine the total amount of isocyanate in a sample THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2003-12-02 US claimed
EP-1077962-A2 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services (US) 2001-02-28 EP claimed
WO-1999058517-A2 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-11-18 WO claimed
EP-1077962-B1 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE US GOV HEALTH & HUMAN SERV (US) 2005-04-13 EP disclosed
US-6656737-B1 Reacting 9-anthracenemethanol, pyridine, and p-nitrophenyl chloroformate; reacting the product with an amine, especially piperazine, to form a product that can be used to determine the total amount of isocyanate in a sample THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2003-12-02 US disclosed
EP-1077962-A2 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services (US) 2001-02-28 EP disclosed
WO-1999058517-A2 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-11-18 WO disclosed